Parallel Advisors LLC grew its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 4.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 84,775 shares of the company’s stock after purchasing an additional 3,638 shares during the quarter. Parallel Advisors LLC’s holdings […]
Colgate-Palmolive (NYSE:CL – Get Free Report) had its price objective increased by research analysts at Morgan Stanley from $101.00 to $103.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Morgan Stanley’s target price would suggest a potential upside of 12.20% from the stock’s current […]
JARISLOWSKY FRASER Ltd trimmed its position in Colgate-Palmolive (NYSE:CL – Free Report) by 5.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 630,312 shares of the company’s stock after selling 37,966 shares during the quarter. JARISLOWSKY FRASER Ltd owned 0.08% of Colgate-Palmolive worth […]
Skopos Labs Inc. acquired a new stake in Colgate-Palmolive (NYSE:CL – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,922 shares of the company’s stock, valued at approximately $392,000. A number of other institutional investors and hedge funds have […]
Founders Financial Alliance LLC bought a new stake in Colgate-Palmolive (NYSE:CL – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 2,666 shares of the company’s stock, valued at approximately $212,000. Other institutional investors have also modified their […]